Display Settings:

Format

Send to:

Choose Destination
    Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S137-41.

    Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.

    Source

    Intensive Care Unit, Hospital Universitario Virgen del Rocio, Sevilla, Spain. jose.garnacho.sspa@juntadeandalucia.es

    Abstract

    Echinocandins are the treatment of choice for patients with severe forms of candidaemia, including neutropenic patients and those episodes presenting with shock. There is little distinction between the three available echinocandins (caspofungin, anidulafungin and micafungin), but there is more clinical experience with caspofungin. Identifying patients who will benefit from early antifungal therapy using clinical tools such as the 'Candida Score' is an interesting strategy that may reduce the high mortality in critically ill patients with invasive fungal infections.

    PMID:
    19013338
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk